Dividends
Dividend payments are $2.40 per share, with a current dividend yield of 1.21%. The company has dividend history for 13 consecutive years.
RMD Dividend Summary
1.21%
$2.40
23.21%
20.14%
Consecutive Years
13
Most Recent Ex-Date
May 14, 2026
Most Recent Payment
Jun 18, 2026
RMD Dividends per Share (Nominal History)
View full nominal table listThis step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.
RMD Dividends CAGR Chart
ResMed Inc. (RMD)
Annual Dividend History
| Year | Dividend/Share | YoY Growth |
|---|---|---|
| 2026(YTD) | $1.20 | — |
| 2025 | $2.26 | +11.88% |
| 2024 | $2.02 | +9.78% |
| 2023 | $1.84 | +6.98% |
| 2022 | $1.72 | +6.17% |
| 2021 | $1.62 | +3.85% |
| 2020 | $1.56 | +2.63% |
| 2019 | $1.52 | +5.56% |
| 2018 | $1.44 | +5.88% |
| 2017 | $1.36 | +7.94% |
| 2016 | $1.26 | +8.62% |
| 2015 | $1.16 | +9.43% |
| 2014 | $1.06 | +26.19% |
| 2013 | $0.84 | N/A |
| 2012 | $0.34 | N/A |
Quarterly Dividend History
| Quarter | Dividend/Share | YoY Growth |
|---|---|---|
| Q2 2026 | $0.60 | +13.21% |
| Q1 2026 | $0.60 | +13.21% |
| Q4 2025 | $0.60 | +13.21% |
| Q3 2025 | $0.60 | +13.21% |
| Q2 2025 | $0.53 | +10.42% |
| Q1 2025 | $0.53 | +10.42% |
| Q4 2024 | $0.53 | +10.42% |
| Q3 2024 | $0.53 | +10.42% |
| Q2 2024 | $0.48 | +9.09% |
| Q1 2024 | $0.48 | +9.09% |
| Q4 2023 | $0.48 | +9.09% |
| Q3 2023 | $0.48 | +9.09% |
| Q2 2023 | $0.44 | +4.76% |
| Q1 2023 | $0.44 | +4.76% |
| Q4 2022 | $0.44 | +4.76% |
| Q3 2022 | $0.44 | +4.76% |
| Q2 2022 | $0.42 | +7.69% |
| Q1 2022 | $0.42 | +7.69% |
| Q4 2021 | $0.42 | +7.69% |
| Q3 2021 | $0.42 | +7.69% |
| Q2 2021 | $0.39 | +0.00% |
| Q1 2021 | $0.39 | +0.00% |
| Q4 2020 | $0.39 | +0.00% |
| Q3 2020 | $0.39 | +0.00% |
Dividend Yield Metrics
- Current Yield
- 1.21%
- Average Yield (TTM)
- 1.21%
- Average Yield (3Y)
- 1.03%
- Forward Yield on Cost (3Y)
- 1.69%
- Forward Yield on Cost (5Y)
- 2.10%
- Forward Yield on Cost (10Y)
- 3.67%
Payout Ratio Analysis
- Payout Ratio (Current)
- 23.21%
- FCF Payout Ratio
- 20.14%
- Payout Ratio (3Y Avg)
- 27.61%
- Payout Ratio (5Y Avg)
- 32.92%
- FCF Payout (3Y Avg)
- 30.44%
- FCF Payout (5Y Avg)
- 51.61%
Dividend Coverage
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell